Perricone C - Search Results

1

Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Autoimmune Rheumatic and Non Rheumatic Diseases.

Manfredi M, Van Hoovels L, Benucci M, De Luca R, Coccia C, Bernardini P, Russo E, Amedei A, Guiducci S, Grossi V, Bossuyt X, Perricone C, Infantino M. Manfredi M, et al. Among authors: perricone c. J Pers Med. 2023 Apr 19;13(4):688. doi: 10.3390/jpm13040688. J Pers Med. 2023. PMID: 37109074 Free PMC article. Review.

2

Stem cells in autoimmune diseases: Implications for pathogenesis and future trends in therapy.

Cipriani P, Carubbi F, Liakouli V, Marrelli A, Perricone C, Perricone R, Alesse E, Giacomelli R. Cipriani P, et al. Among authors: perricone r, perricone c. Autoimmun Rev. 2013 May;12(7):709-16. doi: 10.1016/j.autrev.2012.10.004. Epub 2012 Nov 24. Autoimmun Rev. 2013. PMID: 23183379 Review.

3

IL-35: a new immunomodulator in autoimmune rheumatic diseases.

Sakkas LI, Mavropoulos A, Perricone C, Bogdanos DP. Sakkas LI, et al. Among authors: perricone c. Immunol Res. 2018 Jun;66(3):305-312. doi: 10.1007/s12026-018-8998-3. Immunol Res. 2018. PMID: 29749583 Review.

4

Tackling the autoimmune side in Spondyloarthritis: A systematic review.

Chimenti MS, Perricone C, Conigliaro P, Triggianese P, D'Antonio A, de Martino E, Fonti GL, Caso F, Costa L, Perricone R. Chimenti MS, et al. Among authors: perricone r, perricone c. Autoimmun Rev. 2020 Oct;19(10):102648. doi: 10.1016/j.autrev.2020.102648. Epub 2020 Aug 13. Autoimmun Rev. 2020. PMID: 32801035

5

Contribution of Janus-Kinase/Signal Transduction Activator of Transcription Pathway in the Pathogenesis of Vasculitis: A Possible Treatment Target in the Upcoming Future.

Bursi R, Cafaro G, Perricone C, Riccucci I, Calvacchi S, Gerli R, Bartoloni E. Bursi R, et al. Among authors: perricone c. Front Pharmacol. 2021 Mar 29;12:635663. doi: 10.3389/fphar.2021.635663. eCollection 2021. Front Pharmacol. 2021. PMID: 33854436 Free PMC article. Review.

6

Exploring the Link between Plasma Levels of PCSK9, Immune Dysregulation and Atherosclerosis in Patients with Primary Sjögren's Syndrome.

Bianconi V, Cafaro G, Mannarino MR, Perricone C, Cosentini E, Bistoni O, Paltriccia R, Lombardini R, Gerli R, Pirro M, Bartoloni E. Bianconi V, et al. Among authors: perricone c. Biomolecules. 2023 Sep 12;13(9):1384. doi: 10.3390/biom13091384. Biomolecules. 2023. PMID: 37759784 Free PMC article.

7

Anti-Saccharomyces cerevisiae autoantibodies in autoimmune diseases: from bread baking to autoimmunity.

Rinaldi M, Perricone R, Blank M, Perricone C, Shoenfeld Y. Rinaldi M, et al. Among authors: perricone r, perricone c. Clin Rev Allergy Immunol. 2013 Oct;45(2):152-61. doi: 10.1007/s12016-012-8344-9. Clin Rev Allergy Immunol. 2013. PMID: 23292495 Review.

8

Colchicine, an anti-rheumatic agent, as a potential compound for the treatment of COVID-19.

Perricone C, Bartoloni E, Gerli R. Perricone C, et al. Reumatologia. 2020;58(5):261-264. doi: 10.5114/reum.2020.100088. Epub 2020 Oct 20. Reumatologia. 2020. PMID: 33227067 Free PMC article. No abstract available.

9

The facts and fictions of precision medicine in autoimmune diseases: is the machine learning approach the response?

Bartoloni E, Perricone C, Cafaro G, Alunno A, Gerli R. Bartoloni E, et al. Among authors: perricone c. Rheumatology (Oxford). 2022 Feb 2;61(2):484-485. doi: 10.1093/rheumatology/keab715. Rheumatology (Oxford). 2022. PMID: 34534273 No abstract available.

10

Genetic Factors of Autoimmune Diseases 2017.

Ceccarelli F, Agmon-Levin N, Perricone C. Ceccarelli F, et al. Among authors: perricone c. J Immunol Res. 2017;2017:2789242. doi: 10.1155/2017/2789242. Epub 2017 Nov 5. J Immunol Res. 2017. PMID: 29270439 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

268 results

Search Page